• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于卡尔曼滤波的新型胰岛素泵精度评估方法。

Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy.

机构信息

Air Liquide Healthcare, Explor Center, Gentilly, France.

Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Paris, France.

出版信息

Diabetes Technol Ther. 2019 Oct;21(10):557-565. doi: 10.1089/dia.2019.0147.

DOI:10.1089/dia.2019.0147
PMID:31335164
Abstract

Insulin pump or continuous subcutaneous insulin infusion (CSII) system is a widely adopted contemporary treatment for type 1 diabetes and is a major component of an artificial pancreas (AP). CSII accuracy is essential for glycemic control and to-date such metric has not been given sufficient study, especially at the range of the lowest basal rate. The gold-standard assessment method IEC (International Electrotechnical Commission) 60601-2-24 has some limitations. Our study presents a new accurate and reactive method for CSII system evaluation based on direct flow measurement. A leading-edge assessment method based on a double measurement approach utilizing a direct mass flow meter and a time-stamped microgravimetric bench test was combined with a Bayesian-based mathematical filter (Kalman). The performance of this new method was evaluated while assessing the delivery precision of an off-the-shelf insulin pump at several basal rates. The proposed methodology offers a double reading-volume and flow rate-which provides direct instantaneous flow rate. CSII dose errors were evaluated using mean absolute relative dispersion (MARD) at different time intervals windows over the whole test. The metrological aspect of the measurements and filtering performance were consistent. CSII precision is shown to be different in terms of the flow rate value: MARD (2 UI/h) = 12.7%, MARD (0.5 UI/h) = 20.4%, and MARD (0.1 UI/h) = 65.0%. MARD (2 UI/h) = 8.1%, (0.5 UI/h), MARD (0.5 UI/h) = 18.8%, and MARD (0.1 UI/h) = 18.4%. Instantaneous flow rate results highlight an irregular stroke-based delivery. This new method to assess insulin pump administration has been validated and highlights the current imprecision in insulin delivery, especially for the lowest basal rate, which is mainly used in pediatric cases and AP system delivery. This leading-edge method should be used to precisely compare several CSII performances in those contexts.

摘要

胰岛素泵或连续皮下胰岛素输注(CSII)系统是目前治疗 1 型糖尿病的广泛采用的方法,也是人工胰腺(AP)的重要组成部分。CSII 的准确性对于血糖控制至关重要,但迄今为止,这种指标尚未得到充分研究,尤其是在最低基础率范围内。金标准评估方法 IEC(国际电工委员会)60601-2-24 存在一些局限性。我们的研究提出了一种新的基于直接流量测量的 CSII 系统评估准确且反应灵敏的方法。一种基于双测量方法的先进评估方法,该方法利用直接质量流量计和时间标记微量天平测试相结合,并结合基于贝叶斯的数学滤波器(卡尔曼)。在评估几种基础率下市售胰岛素泵的输送精度时,评估了这种新方法的性能。该方法提供了双读数-体积和流量率-提供直接的瞬时流量率。使用不同时间间隔窗口的平均绝对相对分散度(MARD)评估 CSII 剂量误差。测量和过滤性能的计量方面是一致的。根据流量值,CSII 精度不同:MARD(2 UI/h)= 12.7%,MARD(0.5 UI/h)= 20.4%,MARD(0.1 UI/h)= 65.0%。MARD(2 UI/h)= 8.1%,(0.5 UI/h),MARD(0.5 UI/h)= 18.8%,MARD(0.1 UI/h)= 18.4%。瞬时流量结果突出了基于不规则冲程的输送。这种评估胰岛素泵给药的新方法已得到验证,并突出了目前胰岛素输送的不准确性,尤其是最低基础率,主要用于儿科病例和 AP 系统输送。在这些情况下,应使用这种先进的方法来精确比较几种 CSII 的性能。

相似文献

1
Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy.基于卡尔曼滤波的新型胰岛素泵精度评估方法。
Diabetes Technol Ther. 2019 Oct;21(10):557-565. doi: 10.1089/dia.2019.0147.
2
All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.并非所有胰岛素泵都等效:几种基础率的基准测试评估。
Diabetes Technol Ther. 2020 Jun;22(6):476-483. doi: 10.1089/dia.2019.0486. Epub 2020 Mar 18.
3
Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.不同胰岛素输注系统输注剂量的准确性。
Diabetes Technol Ther. 2019 Apr;21(4):201-208. doi: 10.1089/dia.2018.0376. Epub 2019 Mar 22.
4
An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.在线葡萄糖传感器-胰岛素泵系统故障检测方法:提高 1 型糖尿病患者夜间安全性
IEEE Trans Biomed Eng. 2013 Feb;60(2):406-16. doi: 10.1109/TBME.2012.2227256. Epub 2012 Nov 15.
5
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.持续皮下胰岛素输注治疗:胰岛素泵入门知识。
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122.
6
Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion.当前无管胰岛素输注连续皮下胰岛素泵精度评估。
Diabetes Technol Ther. 2021 May;23(5):350-357. doi: 10.1089/dia.2020.0525. Epub 2020 Dec 22.
7
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.1型糖尿病中,与单纯持续皮下胰岛素输注相比,传感器增强泵治疗的长期健康经济效益:英国视角
J Med Econ. 2016;19(3):236-42. doi: 10.3111/13696998.2015.1113979. Epub 2015 Nov 19.
8
Continuous subcutaneous insulin infusion (CSII) pumps.持续皮下胰岛素输注(CSII)泵。
Adv Exp Med Biol. 2012;771:414-9. doi: 10.1007/978-1-4614-5441-0_29.
9
Insulin pump therapy in childhood diabetes mellitus: guidelines for use.儿童糖尿病的胰岛素泵治疗:使用指南
Treat Endocrinol. 2003;2(1):11-21. doi: 10.2165/00024677-200302010-00002.
10
Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation.描述一种新型胰岛素给药贴片泵及其比较准确性评估。
J Diabetes Sci Technol. 2022 Jul;16(4):971-975. doi: 10.1177/19322968211000441. Epub 2021 Mar 19.

引用本文的文献

1
New ex vivo method to objectively assess insulin spatial subcutaneous dispersion through time during pump basal-rate based administration.一种新的离体方法,可在泵基础率给药期间通过时间客观评估胰岛素的空间皮下分散。
Sci Rep. 2023 Nov 16;13(1):20052. doi: 10.1038/s41598-023-46993-1.
2
Insulin Delivery Hardware: Pumps and Pens.胰岛素输送器械:泵和笔。
Diabetes Technol Ther. 2021 Jun;23(S2):S32-S45. doi: 10.1089/dia.2021.2503.